Evidence map›Paper›PMID 27911167›Full record

ReviewEpigenetics2018

Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains.

David Monk, Joannella Morales, Johan T den Dunnen, Silvia Russo, Franck Court, Dirk Prawitt, Thomas Eggermann, Jasmin Beygo, Karin Buiting, Zeynep Tümer and 1 more

Abstract readReview
In one paragraph

Review in Epigenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Epigenetics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genome-wide DNA methylation changes in human spermatogenesis.American journal of human genetics · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David Monka Imprinting and Cancer group, Cancer Epigenetic and Biology Program, Bellvitge Biomedical Research Institute , Barcelona , Spain.ORCID 0000-0001-8991-0497
Joannella Moralesb European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus , Hinxton, Cambridge , UK.
Johan T den Dunnenc Human Genetics and Clinical Genetics, Leiden University Medical Center , Leiden , the Netherlands.
Silvia Russod Laboratory of Cytogenetics and Molecular Genetics, Istituto Auxologico Italiano , Milan , Italy.
Franck Courte Reproduction and Developmental Genetics , Centre National de la Recherche Scientifique , Clermont-Ferrand , France.
Dirk Prawittf Center for Pediatrics and Adolescent Medicine, Johannes Gutenberg University Medical Center, Obere Zahlbacher , Mainz , Germany.
Thomas Eggermanng Institute of Human Genetics, Technical University of Aachen , Aachen , Germany.
Jasmin Beygoh Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen , Germany.
Karin Buitingh Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen , Germany.
Zeynep Tümeri Applied Human Molecular Genetics, Kennedy Centre, Copenhagen University Hospital, Rigshospitalet , Glostrup , Denmark.
Nomenclature group of the European Network for Human Congenital Imprinting Disorders

Funding

Wellcome Trust
6 · The paper itself

Abstract

The analysis of DNA methylation has become routine in the pipeline for diagnosis of imprinting disorders, with many publications reporting aberrant methylation associated with imprinted differentially methylated regions (DMRs). However, comparisons between these studies are routinely hampered by the lack of consistency in reporting sites of methylation evaluated. To avoid confusion surrounding nomenclature, special care is needed to communicate results accurately, especially between scientists and other health care professionals. Within the European Network for Human Congenital Imprinting Disorders we have discussed these issues and designed a nomenclature for naming imprinted DMRs as well as for reporting methylation values. We apply these recommendations for imprinted DMRs that are commonly assayed in clinical laboratories and show how they support standardized database submission. The recommendations are in line with existing recommendations, most importantly the Human Genome Variation Society nomenclature, and should facilitate accurate reporting and data exchange among laboratories and thereby help to avoid future confusion.

Indexed as

DNA MethylationGenomic ImprintingTerminology as TopicAnimalsEpigenomicsHumansPolymorphism, GeneticPractice Guidelines as TopicImprintingimprinting disordersmethylationnomenclature

Identifiers

PMID27911167
PMCPMC5873357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.